This randomized clinical trial assesses whether stereotactic radiation, compared with hippocampal-avoidance whole brain radiation, improves symptom severity and interference with daily functioning in US patients with 5 to 20 brain metastases and no prior brain-directed radiation.
JAMA (Journal of the American Medical Association) published a clinical update in Research Highlights on 07 Apr 2026.
The item focuses on Stereotactic Radiation vs Hippocampal-Avoidance Whole Brain Radiation.
Review the original article for the full source wording and details.